NovaBridge Biosciences Equity Securities, FV-NI, Unrealized Gain (Loss)
NovaBridge Biosciences (NBP) reported Equity Securities, FV-NI, Unrealized Gain (Loss) of -$5.16 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss · last filed 2026-04-07
| Period end | Equity Securities, FV-NI, Unrealized Gain (Loss) 12 month |
|---|---|
| 2025-12-31 | -$5.16M 20-F · filed 2026-04-07 |